03:46 AM EDT, 06/21/2024 (MT Newswires) -- Sarah Boyce, Director, President and Chief Executive Officer, on June 17, 2024, sold 32,074 shares in Avidity Biosciences ( RNA ) for $1,255,040. Following the Form 4 filing with the SEC, Boyce has control over a total of 142,543 shares of the company, with 142,543 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990124000109/xslF345X03/wk-form4_1718923667.xml

Price: 36.86, Change: -0.75, Percent Change: -1.99